CMLD-2
CAS No. 958843-91-9
CMLD-2( —— )
Catalog No. M34849 CAS No. 958843-91-9
CMLD-2 is an inhibitor of HuR-ARE interaction (Ki: 350 nM) that competitively binds HuR protein and disrupts its interaction with adenine element-rich (ARE) mRNA targets.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 258 | In Stock |
|
| 5MG | 235 | In Stock |
|
| 10MG | 392 | In Stock |
|
| 25MG | 642 | In Stock |
|
| 50MG | 877 | In Stock |
|
| 100MG | 1181 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2353 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCMLD-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionCMLD-2 is an inhibitor of HuR-ARE interaction (Ki: 350 nM) that competitively binds HuR protein and disrupts its interaction with adenine element-rich (ARE) mRNA targets.
-
DescriptionCMLD-2, an inhibitor of HuR-ARE interaction, competitively binds HuR protein disrupting its interaction with adenine-uridine rich elements (ARE)-containing mRNAs (Ki=350 nM). CMLD-2 induces apoptosis exhibits antitumor activity in different cancer cells as colon, pancreatic, thyroid and lung cancer cell lines. Hu antigen R (HuR) is an RNA binding protein, can regulate target mRNAs stability and translation.
-
In VitroCell Viability Assay Cell Line:SW1736, 8505C, BCPAP and K1 cells Concentration:1, 5, 10, 25, 35, 50, 75 μM Incubation Time:24, 48, 72 hours Result:Reduced the viability of all the four cell lines when used at 35, 50 and 75?μM concentration and at different time points.Apoptosis AnalysisCell Line:H1299, A549, H1975, HCC827, MRC-9 and CCD16 cells Concentration:20, 30 μM Incubation Time:24, 48 hours Result:Marked activated the caspase-9 and -3 in lung tumor cells.Induce the cleavage of PARP in lung tumor cells.Significantly increased the annexin-V-positive staining in lung tumor cells.Cell Cycle Analysis Cell Line:H1299, A549, MRC-9 and CCD16 cells Concentration:30 μM Incubation Time:24, 48 hours Result:Induced greater G1 phase cell cycle arrest in H1299 and A549 cells than in MRC-9 and CCD16 cells.Western Blot Analysis Cell Line:H1299, A549, H1975, HCC827, CCD16 and MRC-9 cells Concentration:20, 30 μM Incubation Time:24, 48 hours Result:Diminished protein expression of HuR, Bcl-2, Cyclin E and Bcl-XL and increased expression of p27 and BAX in lung tumor cells.
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis | HuR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number958843-91-9
-
Formula Weight513.58
-
Molecular FormulaC31H31NO6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (97.36 mM; Ultrasonic )
-
SMILESCOc1ccc(cc1)C(CC(=O)N1CCCC1)c1c(OC)cc(OC)c2c(cc(=O)oc12)-c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
CP 461
CP 461 (UNII-68OJX9I7DT), a specific PDE2A inhibitor, is a novel pro-apoptotic compound that inhibits cyclic GMP phosphodiesterase but not cyclooxygenase-1 or -2.
-
CTA 056
CTA 056 is an interleukin-2 induced T cell kinase (ITK) inhibitor, inhibits the growth of MOLT-4 xenograft tumors in mice, induces apoptosis in Jurkat cells, and can be used in the study of autoimmune disorders and T cell malignancies.
-
Exisulind
Exisulind induces apoptosis through the activation of protein kinase G (PKG). Exisulind exhibits antineoplastic activity in solid tumour and haematological cancer cell lines and is an inhibitor of tumour growth in rodent models of colon, prostate, bladder, mammary and lung cancer.
Cart
sales@molnova.com